Product Reports Resources Pricing Login Book a demo

OptoMedic

Health Tech & Medtech · Foshan, China · Founded 2013

A high-tech company committed to providing high-performance medical devices and services utilizing cutting-edge optical and bio-optical technologies in the medical field MoreLess

Guangdong OptoMedic Technologies Inc., established in July 2013, is a medical device manufacturer specializing in advanced optical and bio-optical technologies for the medical field. The company was founded by a multidisciplinary team of experts, including Dr. An Xin, and is headquartered in Foshan, Guangdong, with research, development, and marketing centers in several Chinese cities. OptoMedic focuses on developing and producing high-end medical equipment, with a particular emphasis on endoscopic systems for minimally invasive surgery.

The company's business model revolves around the design, manufacturing, and sale of sophisticated medical imaging devices directly and through distribution networks to healthcare providers. Its primary clients are top-tier hospitals, with its products being used in over 500 such institutions in China and internationally in countries like Germany and Italy. The firm generates revenue through the sale of its comprehensive product portfolio, which includes endoscopic camera systems, light sources, and related instruments. To date, the company has successfully completed multiple venture capital funding rounds, including a significant Pre-IPO financing of over RMB 200 million in July 2023, to support product commercialization and global market expansion.

OptoMedic offers a suite of products, including full-function endoscopic imaging platforms, fluorescence and white-light laparoscopes, and single-use endoscopes. A flagship product is its intraoperative endoscopic fluorescence navigation system, such as the FloNavi series. This system utilizes Indocyanine Green (ICG), a fluorescent dye, which, when illuminated by near-infrared light, allows surgeons to visualize patient anatomy in real-time. Key features include high-definition white light imaging, highly sensitive fluorescence detection, and the ability to switch between multiple imaging modes, including 4K and 3D views. This technology aids surgeons in procedures such as mapping lymph nodes, assessing tissue perfusion, and identifying tumor boundaries. The company has secured numerous patents and has received regulatory approvals for its products from China's NMPA and the U.S. FDA.

Keywords: medical devices, endoscopic surgery, fluorescence guided surgery, laparoscopes, medical imaging, minimally invasive surgery, surgical navigation, Indocyanine Green, ICG imaging, 4K endoscopy, 3D endoscopy, surgical instruments, medtech, bio-optical technology, hospital equipment, surgical visualization, cancer screening equipment, diagnostic equipment, perfusion assessment, lymph node mapping, Foshan

Company overview

OptoMedic company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2013
Headquarters
Foshan, China
Employees
35
Open positions
None listed
Dealroom signal
43.5
client focusb2btechnologyDeep Techsub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorSurgerysectorMedical ImagingsectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

OptoMedic funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
OtherOther financing Dec 2023 $0 Kunpeng Capital
LATE VCEquity / VC Jul 2023 $28M $110M Binfu Capital · Guosen H&S Investments · China Construction Bank · Huajin Capital
LATE VCEquity / VC Sep 2022 $0 Alibaba
SERIES DEquity / VC Jul 2021 Primavera Capital Group · SDIC Capital
SERIES CEquity / VC Apr 2020 $14M $55M Undisclosed
SERIES BEquity / VC May 2018 THG Ventures · Guangdong Western Investment Management
SERIES AEquity / VC Apr 2016 Fortune Venture · THG Ventures · Insight Capital
Showing 7 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 34
2025 34
2024 23
2023 27
2022 22
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

OptoMedic website traffic

Latest recorded traffic for OptoMedic is 20 monthly website visits, down 97.6% over the last three months. OptoMedic's team grew 2.9% over the past year.

Latest monthly visits20 3-month web change-97.6% 1-year team growth+2.9%
Monthly website visits63 observations · Oct 2020–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

OptoMedic compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

OptoMedic's talent

Book a demo to see the people
Employees 35 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

12 investors on OptoMedic's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 4 investors entered at this stage
Fortune Venture
THG Ventures
Insight Capital
Guangdong Western Investment Management
Series B+ 7 investors entered at this stage
Primavera Capital Group
SDIC Capital
Alibaba
China Construction Bank
Huajin Capital
Binfu Capital
Guosen H&S Investments
Other known 1 additional known investor
Kunpeng Capital

Global footprint

Where OptoMedic has talent and traffic

Workforce by country
2 countries with
team presence
🇨🇳 China88.9%
🇺🇸 United States11.1%
2 countries shown

In the news

Latest news about OptoMedic

Recent press, funding announcements, and product moves mentioning OptoMedic — open to read from the original sources.

See all news

Market sentiment

What the market is saying about OptoMedic

An AI-synthesized read of the highest-engagement posts about OptoMedic on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See OptoMedic’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.